Medtronic and Cornerstone Robotics Expand Robotic Surgery
Hong Kong, September 1, 2026 Cornerstone Robotics and Medtronic have entered into a strategic partnership designed to expand global...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Hong Kong, September 1, 2026 Cornerstone Robotics and Medtronic have entered into a strategic partnership designed to expand global...
Caesarea, Israel, August 7, 2026 IceCure Medical has announced a significant expansion of its U.S. post-marketing clinical program with...
Nantong, China, August 7, 2026 Ractigen Therapeutics has announced a significant milestone in the development of its investigational RNA...
Nutley, New Jersey, USA, August 5, 2026 Reckitt has received U.S. Food and Drug Administration (FDA) approval for Mucinex®...
Galway, Ireland, August 6, 2026 Medtronic has secured an expanded CE Mark indication for its Afferaâ„¢ Mapping and Ablation...
CLEVELAND, Ohio and HOUSTON, Texas, June 5, 2026 Neuronoff has achieved a major clinical milestone with the successful implantation...
WHITE PLAINS, New York, June 5, 2026 Retia Medical has announced a significant expansion of its commercial partnership with...
GALWAY, Ireland, May 20, 2026 Medtronic plc has announced its intent to acquire SPR Therapeutics, Inc. in a deal...
Galway, Ireland & Chicago, Illinois | April 25, 2026 Medtronic has announced significant clinical milestones for its Afferaâ„¢ mapping...
Galway, Ireland | March 23, 2026 Medtronic plc has announced that the U.S. Food and Drug Administration (FDA) has...
